Federal schedules of common controlled drugs
Question
A pharmacy technician is updating a quick-reference chart of the controlled drugs the pharmacy stocks. For each product, select its schedule under the federal Controlled Substances Act.
| Row | Schedule II | Schedule III | Schedule IV | Schedule V |
|---|---|---|---|---|
| Lisdexamfetamine dimesylate capsules | ✓ Correct | Not correct | Not correct | Not correct |
| Buprenorphine and naloxone sublingual tablets | Not correct | ✓ Correct | Not correct | Not correct |
| Tramadol hydrochloride tablets | Not correct | Not correct | ✓ Correct | Not correct |
| Pregabalin capsules | Not correct | Not correct | Not correct | ✓ Correct |
Answer
Lisdexamfetamine dimesylate capsules: Schedule II · Buprenorphine and naloxone sublingual tablets: Schedule III · Tramadol hydrochloride tablets: Schedule IV · Pregabalin capsules: Schedule V
Rationale
Lisdexamfetamine is a schedule II stimulant, while buprenorphine and naloxone tablets contain schedule III buprenorphine. Tramadol is schedule IV and pregabalin is schedule V.
Sources
Sources marked “Adapted from” are licensed under CC BY 4.0. We changed the material: its facts are rewritten into an original question, answer options and rationale. The original authors and publishers do not endorse SwipeExam.
- United States Department of Justice
- Lisdexamfetamine Dimesylate (lisdexamfetamine) oral prescribing information, Amneal Pharmaceuticals LLC
- buprenorphine hydrochloride and naloxone hydrochloride dihydrate (buprenorphine hydrochloride and naloxone hydrochloride dihydrate) sublingual prescribing information, REMEDYREPACK INC.
- tramadol hydrochloride (tramadol hydrochloride) oral prescribing information, Strides Pharma Science Limited
- Adapted from Open RN Nursing: Mental Health and Community Concepts, 2nd edition: SUBSTANCE USE DISORDERS
- Pregabalin (pregabalin) oral prescribing information, Clinical Solutions Wholesale, LLC
- LISDEXAMFETAMINE DIMESYLATE (lisdexamfetamine dimesylate) oral prescribing information, Sun Pharmaceutical Industries, Inc.
- jspears on DSK121TN23PROD with CFR
Last verified: 2 independent automated checks Question ptcb-fr-00028, version 1
Checks are automated. No licensed clinician has reviewed this question. Check the sources and your program’s materials.
Report an error in this question. For education only; not medical advice. See all sources and licenses.